Bydureon BCise Fuyll Prescribing Information

den8dhaj6zs0e.cloudfront.net

use BYDUREON BCISE safely and effectively. See full prescribing information for BYDUREON BCISE. BYDUREON BCISE ® (exenatide extended-release) injectable suspension, for subcutaneous use. Initial U.S. Approval: 2005 WARNING: RISK OF THYROID C-CELL TUMORS. See full prescribing information for complete boxed warning.

  Cibse, Bydureon, Bydureon bcise, Use bydureon bcise